Google
DERM — JOURNEY MEDICAL CORP (Healthcare >> Drug Manufacturers - Specialty & Generic)
DERM FAQ
What is DERM's ROE?
JOURNEY MEDICAL CORP reports a Return on Equity (ROE) of -31.10%.
What is DERM's dividend yield?
JOURNEY MEDICAL CORP offers a dividend yield of 0.00%.
What is DERM's Deepscope Quality Score?
Deepscope rates DERM's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy DERM?
Deepscope's AI Timing Score for DERM is 62 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does DERM belong to?
JOURNEY MEDICAL CORP is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.
|
USD 5.97
Price
-0.25
(-4.02%)
Day Change
|
|
|---|
DERM, ファンダメンタルスコアはok ( ファンダメンタル = 62) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.97 |
| PBV / Sector |
5.39 / 2.76
|
| Earning Per Share | -0.34 |
| PE / Sector |
N/A / 23.64
|
| PEG or PE/Growth / Sector |
N/A / 0.13
|
| Average 1M Daily Value |
1.64 M
GREAT
|
| Average 1W Daily Value |
1.06 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
43% |
| ポイントになる統計 |
|
64% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:09:22 |
| Symbol | DERM |
| Name | JOURNEY MEDICAL CORP |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 21.53 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 166.03 / 9,835.56 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 9237 East Via de Ventura Blvd., Scottsdale, AZ, United States, 85258
Phone: 480 434 6670
Website: https://journeymedicalcorp.com
Employees: 58
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
